BOSTON — A test that uses donor-derived cell-free DNA accurately discriminated rejection from non-rejection in kidney transplant recipients and was particularly effective in the discrimination ...

called cell-free DNA, that roam throughout the bloodstream and urine. A common problem in diagnosing infectious disease is that the presence of a potential pathogen in the body does not ...

Natera Inc. has launched the latest version of its test for allograft rejection following kidney transplantation, which now provides the quantity of donor-derived cell-free DNA in addition to the ...

Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation. Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive ...

Short fragments of cell-free DNA (cfDNA) that circulate in blood ... the researchers sequenced plasma-derived cfDNA from COVID-19 patients. They observed high initial lung- and liver-derived ...

They have developed a blood-based method called RARE-seq that detects tumor-derived cell-free RNA with around 50 ... outperforming commonly used DNA-based approaches. RNA from vaccines and many ...

In this article, Dr. Levitsky, who serves as a scientific collaborator to TGI, assesses the utility of donor-derived cell-free DNA (dd-cfDNA) to diagnose graft injury in liver transplant ...

circulating tumor DNA (ctDNA); and transplantation, donor-derived cell-free DNA (ddcfDNA). Cell-Free DNA (cfDNA) Markets focuses on the market for cfDNA analysis instruments, consumables ...